IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
Loading...

PE/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PECy7_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
  • M1slash70_PECy7_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
101215 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101216 100 µg 169€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  2. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  3. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  4. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  5. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  6. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  7. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  8. Okunuki Y, et al. 2018. Proc Natl Acad Sci U S A. 115:E6264. PubMed
  9. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  10. Janbandhu V, et al. 2022. Cell Stem Cell. 29:281. PubMed
  11. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  12. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  13. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  14. Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed
  15. Hiyoshi H, et al. 2022. Cell Host Microbe. 30:163. PubMed
  16. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  17. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  18. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  19. Pannunzio B, et al. 2022. Cells. 11: . PubMed
  20. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  21. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  22. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  23. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  24. Zhang X, et al. 2022. EBioMedicine. 84:104275. PubMed
  25. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  26. Lu Z, et al. 2022. Cell Rep. 41:111482. PubMed
  27. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  28. Yoo HJ, et al. 2022. Cell Rep. 41:111598. PubMed
  29. Papaxenopoulou LA, et al. 2022. iScience. 25:105522. PubMed
  30. Zhang Y, et al. 2022. Front Oncol. 12:1042250. PubMed
  31. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  32. Lee DE, et al. 2022. Nat Commun. 13:7613. PubMed
  33. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  34. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  35. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  36. Leinenga G, et al. 2023. Bioeng Transl Med. 8:e10329. PubMed
  37. Wang R, et al. 2023. iScience. 26:105954. PubMed
  38. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  39. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  40. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  41. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  42. Sheng YH, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:789. PubMed
  43. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  44. Mela V, et al. 2023. Mol Neurobiol. 60:3044. PubMed
  45. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  46. Li L, et al. 2023. iScience. 26:106095. PubMed
  47. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  48. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  49. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  50. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  51. Pastrez PRA, et al. 2023. Cancers (Basel). 15:. PubMed
  52. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  53. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  54. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  55. Lu Y, et al. 2023. J Transl Med. 21:339. PubMed
  56. Bobadilla Muñoz M, et al. 2023. Front Cell Dev Biol. 11:1128534. PubMed
  57. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  58. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  59. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  60. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  61. Cheresh P, et al. 2021. Int J Mol Sci. 22:. PubMed
  62. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  63. Odom CV, et al. 2021. J Immunol. 207:1891. PubMed
  64. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  65. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  66. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  67. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  68. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  69. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  70. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  71. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  72. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  73. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  74. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  75. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  76. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  77. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  78. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  79. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  80. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  81. Jung MY, et al. 2022. Neurooncol Adv. 4:vdac017. PubMed
  82. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  83. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  84. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  85. Li Z, et al. 2021. Immunology. 163:105. PubMed
  86. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  87. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  88. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  89. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  90. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  91. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  92. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  93. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  94. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  95. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  96. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  97. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  98. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  99. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  100. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  101. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  102. Wei H, et al. 2021. Malar J. 20:89. PubMed
  103. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  104. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  105. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  106. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  107. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  108. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  109. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  110. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  111. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  112. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  113. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  114. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  115. Akhmetzyanova ER, et al. 2019. Front Cell Neurosci. 12:507. PubMed
  116. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  117. Gibson EM, et al. 2019. Cell. 176:43:00. PubMed
  118. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  119. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  120. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  121. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  122. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  123. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  124. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  125. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  126. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  127. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  128. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  129. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  130. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  131. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  132. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  133. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  134. Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
  135. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  136. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  137. Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed
  138. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  139. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  140. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  141. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  142. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  143. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  144. Meeks K, et al. 2009. J Immunol. 183:8026. PubMed
  145. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  146. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  147. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  148. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  149. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  150. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  151. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  152. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  153. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  154. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  155. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
  156. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  157. Goldman E, et al. 2021. Cells. 10:. PubMed
  158. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  159. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  160. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  161. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  162. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  163. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  164. Secondini C, et al. 2017. Oncoimmunology. 6:e1316437. PubMed
  165. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  166. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  167. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  168. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  169. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  170. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  171. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  172. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  173. Pérez-Girón J, et al. 2015. J Vis Exp. 100: 52803. PubMed
  174. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  175. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  176. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  177. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  178. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  179. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  180. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  181. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  182. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  183. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  184. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  185. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  186. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  187. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  188. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  189. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  190. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  191. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  192. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  193. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  194. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  195. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  196. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  197. Li H, et al. 2020. Nature. 584:274. PubMed
  198. Sibilio A, et al. 2022. iScience. 25:103790. PubMed
  199. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  200. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  201. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  202. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  203. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  204. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  205. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  206. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  207. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  208. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  209. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  210. Gao C, et al. 2017. Mol Neurobiol.. 10.1007/s12035-016-0318-0. PubMed
  211. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  212. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  213. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  214. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  215. Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed
  216. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  217. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  218. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  219. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  220. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  221. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  222. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  223. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  224. Kim SJ, et al. 2020. Cell Mol Immunol. 17:728. PubMed
  225. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  226. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  227. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  228. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  229. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  230. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  231. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  232. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  233. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  234. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  235. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  236. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  237. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  238. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  239. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  240. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  241. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  242. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  243. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  244. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  245. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  246. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  247. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  248. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  249. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  250. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  251. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  252. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  253. Ivan DC, et al. 2021. Front Immunol. 12:666961. PubMed
  254. Gicheva N, et al. 2016. Biochem Biophys Res Commun. 479:1-4. PubMed
  255. Beauchamp N, et al. 2010. J Virol. 84:10191. PubMed
  256. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  257. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  258. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  259. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  260. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  261. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  262. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  263. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  264. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  265. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  266. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  267. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  268. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  269. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  270. Gourvest M, et al. 2021. Leukemia. . PubMed
  271. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  272. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  273. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  274. Rosen DA, et al. 2019. Sci Transl Med. 11:eaau5266. PubMed
  275. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  276. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  277. Süß P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  278. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  279. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  280. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  281. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  282. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  283. Shin M, et al. 2020. Cell Chem Biol. 314:27. PubMed
  284. Kaiser S, et al. 2020. Glia. 68:2427. PubMed
  285. Aggio-Bruce R, et al. 2020. Mol Neurobiol. . PubMed
  286. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  287. Molgora M, et al. 2020. Cell. 182:886. PubMed
  288. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  289. Groppa E, et al. 2015. EMBO Mol Med. 2015; 7: 1366 - 1384. PubMed
  290. Gharib S, et al. 2014. J Leukoc Biol. 95:9. PubMed
  291. Alfaro M, et al. 2008. Proc Natl Acad Sci U S A. 105:18366. PubMed
  292. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  293. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  294. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  295. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  296. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  297. Monteiro LB, et al. 2020. MethodsX. 7:100938. PubMed
  298. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  299. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  300. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  301. Chavez JS, et al. 2022. Cells. 11:. PubMed
  302. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  303. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  304. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  305. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  306. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  307. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  308. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  309. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  310. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  311. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  312. Gawish R, et al. 2022. Elife. 11:. PubMed
  313. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  314. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  315. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  316. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  317. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  318. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  319. Lalor R, et al. 2019. Nutrients. 11. PubMed
  320. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  321. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  322. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  323. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  324. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  325. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  326. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  327. Young K, et al. 2021. Cell Stem Cell. . PubMed
  328. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
RRID
AB_312798 (BioLegend Cat. No. 101215)
AB_312798 (BioLegend Cat. No. 101216)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account